May 20 |
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
|
May 11 |
TELA Bio, Inc. (TELA) Q1 2024 Earnings Call Transcript
|
May 11 |
TELA Bio First Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.63 loss in 1Q 2023)
|
May 10 |
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 10 |
TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Continued Growth
|
May 9 |
TELA Bio GAAP EPS of -$0.23 beats by $0.29, revenue of $16.6M beats by $0.28M
|
May 9 |
TELA Bio Reports First Quarter 2024 Financial Results
|
Apr 10 |
Syros Pharmaceuticals (SYRS) Soars 22.2%: Is Further Upside Left in the Stock?
|
Apr 8 |
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
|